Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use

Published:2024-01 Issue:1 Volume:40 Page:1-8
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Nie Tina

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40267-024-01045-0.pdf

Reference34 articles.

1. National Cancer Institute. SEER cancer stat facts: bladder cancer. 2022. https://seer.cancer.gov/. Accessed 11 Jan 2024.

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: bladder cancer, version 3.2023. 2023. https://www.nccn.org/. Accessed 11 Jan 2024.

3. Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021–9.

4. Mirabal JR, Taylor JA, Lerner SP. CIS of the bladder: significance and implications for therapy. Bladder Cancer. 2019;5(3):193–204.

5. Goldberg IP, Lichtbroun B, Singer EA, et al. Pharmacologic therapies for non-muscle invasive bladder cancer: current and future treatments. Arch Pharmacol Ther. 2022;4(1):13–22.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use;Drugs & Therapy Perspectives;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP